Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purinergic P2X7 receptor (P2X7R) is a ligand-gated cation channel activated by extracellular ATP. It plays a critical role in inflammation, cancer, neurological disorders, and cardiovascular diseases. Activation of P2X7R leads to ion influx, NLRP3 inflammasome activation, and potentially cell death. Its expression is widespread, particularly in immune cells, the nervous system, and cancer cells, making it a therapeutic target for various conditions.
Ligand-gated ion channel activation; NLRP3 inflammasome activation; Induction of cell death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic Receptor P2X7 (P2X7R).